m-a-istock-537908812
designer491 / iStockphoto.com
2 January 2018Americas

Mallinckrodt to make $1.2bn acquisition

Mallinckrodt has revealed plans to acquire biopharmaceutical company Sucampo Pharmaceuticals for $1.2 billion.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
21 May 2018   The US Court of Appeals for the Federal Circuit has affirmed a patent victory for industrial gases company Praxair against pharmaceutical business Mallinckrodt.
Americas
7 August 2017   Mallinckrodt has acquired InfaCare Pharmaceutical Corporation, a company specialising in the development and commercialisation of pharmaceuticals for neonatal and paediatric patients.

More on this story

Americas
21 May 2018   The US Court of Appeals for the Federal Circuit has affirmed a patent victory for industrial gases company Praxair against pharmaceutical business Mallinckrodt.
Americas
7 August 2017   Mallinckrodt has acquired InfaCare Pharmaceutical Corporation, a company specialising in the development and commercialisation of pharmaceuticals for neonatal and paediatric patients.

More on this story

Americas
21 May 2018   The US Court of Appeals for the Federal Circuit has affirmed a patent victory for industrial gases company Praxair against pharmaceutical business Mallinckrodt.
Americas
7 August 2017   Mallinckrodt has acquired InfaCare Pharmaceutical Corporation, a company specialising in the development and commercialisation of pharmaceuticals for neonatal and paediatric patients.